The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study

PURPOSE: Despite the routine use of phosphodiesterase type-5 inhibitors (PDE-5i) for treatment of erectile dysfunction, their role in prostate cancer (PC) chemoprevention remains unclear with only a few studies exploring the link between PDE-5i use and PC. We tested the association between PDE-5i us...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Urol
Huvudupphovsmän: Jamnagerwalla, Juzar, Howard, Lauren E., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014695/
https://ncbi.nlm.nih.gov/pubmed/27060053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2016.03.172
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk